Antiverse raises £3.5 M ($4.6 M) to advance generative AI antibody design platform
Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M ($4.6 M) to its seed funding. The investment will facilitate the Company’s growth, including appointments to…
Read More...
Read More...